Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Escherichia coli in Europe: an overviewAnalysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, ChinaPlasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, BangladeshCharacteristics of surgical patients receiving inappropriate empiric antimicrobial therapy.Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.Genome Sequence of a Multidrug-Resistant Strain of Klebsiella pneumoniae, BAMC 07-18, Isolated from a Combat Injury Wound.Frequency and factors associated with carriage of multi-drug resistant commensal Escherichia coli among women attending antenatal clinics in central India.Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis.Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting.The microbiome of the chicken gastrointestinal tract.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review.Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.An insight into future antibacterial therapy.Low biological cost of carbapenemase-encoding plasmids following transfer from Klebsiella pneumoniae to Escherichia coli.Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment.Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniaeTG13 antimicrobial therapy for acute cholangitis and cholecystitis.Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin.In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014.Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired β-lactam resistance.Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria.The Occurrence ofblaCTX-M,blaSHV, andblaTEMGenes in Extended-Spectrumβ-Lactamase-Positive Strains ofKlebsiella pneumoniae,Escherichia coli, andProteus mirabilisin Poland
P2860
Q26739860-80864B58-6A10-435B-BF3E-E7F0F8CADC6EQ27015697-83CC0D1B-D282-4794-A89C-1FBEB34F0607Q28481714-C3380AD2-04FE-42A9-9B5E-768D23CD14FDQ28538578-ACDB5F10-07DC-403D-8A01-0152D72D9EECQ30361739-20655687-3BA6-4C39-855A-199F374E31E6Q34058006-D1DA8354-C0CA-46F2-A362-19AA58A60479Q34580610-ADD572A6-B865-4A6E-A80E-FFD24C9F0A05Q34702903-06C4259B-023E-471C-BF6D-E82DA83ADB91Q35104348-2DECE4FF-9B92-491D-A8CE-CE9A7F541540Q36051105-9BDD5F61-17E6-4782-BC7B-862FC34B57CDQ37036459-B015CAE8-44B1-45BD-87FF-8D91E27C1F01Q37203872-E84236F8-8B82-4766-BFCD-44D2D870C467Q37694277-ED2F9A2F-FAD7-4FE2-99B0-BFF371E1E5E9Q38031315-9889359E-8D72-4BE3-A25B-0609916D6F97Q38063968-3C370727-659E-4750-B531-DF40BA19532BQ38068483-5E2DFBFA-613A-45F1-9434-E45C413407CDQ38088261-474D026A-B044-4741-BDC7-5B0A23B43F3FQ38151574-F9B6E231-5D0E-433B-9EDE-8C7BBFEDE25AQ38805792-08CF41FB-5975-4AF4-82A8-5E1E16020FBBQ39528561-BDB4D98B-C319-482C-B097-5F4BF2564CB1Q40552898-08056006-948E-45C2-97B6-2EFCAF0414AEQ40622938-23F90C59-016B-4169-B9BC-E8A7052CCF01Q40735141-16A092CB-F375-44F4-B699-5B6592E3082AQ42277917-7B55D76F-2FB0-4019-B883-0E1BB531BE98Q44513436-A543CE16-44E5-4076-B905-CA534BBF88E7Q45223510-375168DD-5FEF-45AC-9C65-BAC8BA976C6FQ46770277-93D6E49B-CB08-4C46-BF81-B80746F19F2BQ47656787-B4B6120F-495D-46D3-BE95-B4D42002799FQ50503492-10DBF289-7765-4652-95D6-31825DED93F6Q55439787-80C9C8E0-1A8A-478A-8C1B-7A9BAD2F6F71Q59052497-22F0A028-AEDC-480D-9D03-A477886BE6BF
P2860
Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Plasmid-mediated resistance in ...... and implications for therapy.
@en
Plasmid-mediated resistance in ...... and implications for therapy.
@nl
type
label
Plasmid-mediated resistance in ...... and implications for therapy.
@en
Plasmid-mediated resistance in ...... and implications for therapy.
@nl
prefLabel
Plasmid-mediated resistance in ...... and implications for therapy.
@en
Plasmid-mediated resistance in ...... and implications for therapy.
@nl
P2860
P1433
P1476
Plasmid-mediated resistance in ...... and implications for therapy.
@en
P2093
Suzanne Geerlings
P2860
P356
10.2165/11597960-000000000-00000
P577
2012-01-01T00:00:00Z
P6179
1028178758